CVRx CFO Jared Oasheim Steps Down After a Decade
Event summary
- Jared Oasheim, CVRx’s CFO since 2015, is stepping down to pursue other opportunities.
- Oasheim will remain as an advisor through February 2027 to ensure a smooth transition.
- CVRx is initiating a search for a new CFO to replace Oasheim.
- Kevin Hykes and Jared Oasheim will present at the Goldman Sachs Healthcare Conference on June 10, 2026.
The big picture
CVRx’s CFO transition comes at a critical juncture as the company seeks to expand its neuromodulation solutions, particularly its Barostim device. The departure of a long-tenured financial leader could signal internal shifts or external opportunities. The medical device sector is increasingly competitive, and maintaining financial discipline will be key to sustaining growth.
What we're watching
- Leadership Stability
- How quickly CVRx can appoint a successor CFO and whether the transition will impact financial operations.
- Strategic Momentum
- Whether the company can maintain its growth trajectory amid leadership changes.
- Market Perception
- How investors react to the CFO transition, particularly in light of the upcoming conference presentation.
Related topics